Literature DB >> 8443762

Risk factors for breast cancer development.

I C Henderson1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8443762     DOI： 10.1002/1097-0142(19930315)71:6+<2127::aid-cncr2820711602>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  20 in total

1.  ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Xiaodong Sun; Peng Guo; Qunna Li; Masakiyo Sasahara; Yoko Ishii; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

Review 2.  Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Authors:  Nancy Krieger; Ilana Löwy; Robert Aronowitz; Judyann Bigby; Kay Dickersin; Elizabeth Garner; Jean-Paul Gaudillière; Carolina Hinestrosa; Ruth Hubbard; Paula A Johnson; Stacey A Missmer; Judy Norsigian; Cynthia Pearson; Charles E Rosenberg; Lynn Rosenberg; Barbara G Rosenkrantz; Barbara Seaman; Carlos Sonnenschein; Ana M Soto; Joe Thornton; George Weisz
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

3.  Gynecological characteristics related to breast cancer in pre and postmenopausal women.

Authors:  Ismael Pascual Pastor Climente; María Manuela Morales Suárez Varela; José Felipe Magraner Gil; Agustín Llopis González
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

4.  Mammographic changes in postmenopausal women on hormonal replacement therapy.

Authors:  R C Marugg; M J van der Mooren; J H Hendriks; R Rolland; S H Ruijs
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 5.  Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?

Authors:  N Baxter
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

6.  Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis.

Authors:  L Rajkumar; R C Guzman; J Yang; G Thordarson; F Talamantes; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis.

Authors:  Yogi Misra; Pamela A Bentley; Jeffrey P Bond; Scott Tighe; Timothy Hunter; Feng-Qi Zhao
Journal:  Physiol Genomics       Date:  2011-11-15       Impact factor: 3.107

Review 8.  Estrogen replacement therapy in women at increased risk for breast cancer.

Authors:  R Vassilopoulou-Sellin
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

9.  Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.

Authors:  Saba Mohamed El-Gendi; Mohamed Farouk Mostafa
Journal:  Pathol Oncol Res       Date:  2015-11-23       Impact factor: 3.201

10.  Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women's breast cancer tumors.

Authors:  Nassim Faridi; S Zahra Bathaie; Saeid Abroun; Parvaneh Farzaneh; Hamid Karbasian; Fuyuhiko Tamanoi; Mohammad-Ali Mohagheghi
Journal:  Cytotechnology       Date:  2018-01-29       Impact factor: 2.058
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.